Daniel F. Zimmerman

Senior Attorney
New York,  NY  U.S.A.
Phone212 504 5663

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Corporate
  • Corporate Finance
  • Corporate Governance
  • Mergers & Acquisitions
 
University Vanderbilt University, B.E., 1994; Columbia Business School, M.B.A., 2001
 
Law SchoolColumbia Law School, J.D., 2001
 
Admitted2002, New York
 
Biography

Dan Zimmerman's practice focuses on securities regulation, mergers and acquisitions, tender offers and exchange offers, securities offerings, corporate finance and corporate governance. He has represented public and private buyers and sellers in a variety of negotiated and contested domestic and cross-border transactions, securities offerings and other financings.

Prior to joining Cadwalader, Dan served in the Division of Corporation Finance of the Securities and Exchange Commission (“SEC”), where he advised on mergers and acquisitions, initial public offerings, debt restructurings, proxy materials, going-private transactions, resale registration statements and periodic reports. While at the SEC, he also prepared responses to no-action requests.

A graduate of Vanderbilt University, Dan received his M.B.A. at Columbia Business School and his J.D. from Columbia Law School. He is admitted to practice in the State of New York.

News & Resources

NEWS

News Releases

Cadwalader Recognized by The American Lawyer With Two 2014 Global Legal Awards

Jul 11, 2014

Cadwalader Advises Elan Corporation, plc in US$8.6 billion sale to Perrigo Company plc

Dec 18, 2013

Recognition

Cadwalader Recognized by The American Lawyer With Two 2014 Global Legal Awards

Jul 11, 2014

Experience

Representative matters on which Dan has worked include representing:
•Salix Pharmaceuticals in its proposed combination with Cosmo Technologies to form Salix Pharmaceuticals, plc.
•Elan Corporation in connection with its
•$8.6 billion acquisition by Perrigo Company
•successful defense of a hostile tender offer by Royalty Pharma
•$1 billion share repurchase
•Rule 144A offering of $850 million in aggregate principal amount of senior notes
•Coca-Cola Enterprises Inc. (“CCE”) in the acquisition of its North American business by The Coca-Cola Company and the simultaneous split off of CCE's European business and CCE's acquisition of The Coca-Cola Company's bottling operations in Norway and Sweden, with a transaction value of approximately $12.5 billion.
•Validus Holdings Ltd. in its successful unsolicited offer to buy IPC Holdings Ltd. for approximately $1.65 billion.
•The Great Atlantic & Pacific Tea Company, Inc. (“A&P”) in its acquisition of Pathmark Stores, Inc. for approximately $1.3 billion.
•Issuers and borrowers, underwriters, initial purchasers and lenders in various high yield and investment grade bond offerings and investment grade and leveraged finance transactions.

 
ISLN922693701
 
Profile Visibility
#8,532 in weekly profile views out of 96,212 lawyers in New York, New York
#111,830 in weekly profile views out of 1,616,736 total lawyers Overall

Office Information

Daniel F. Zimmerman


New YorkNY 10281-0006




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now